Acadia Signs Licensing Deal for Essential Tremor Drug Candidate
Acadia Pharmaceuticals Announces Exclusive License Agreement With Saniona For SAN711; Under The Terms Of The License Agreement, Saniona Will Receive $28M Upfront Plus Potential Milestone Payments Of Up To $582M
Express News | ACADIA Pharmaceuticals Inc - Saniona to Receive $28 Million Upfront Plus up to $582 Million in Milestones
Express News | ACADIA Pharmaceuticals Inc - to Initiate Phase 2 Study of San711 in 2026
Express News | ACADIA Pharmaceuticals Announces Exclusive License Agreement With Saniona for San711
Acadia Pharmaceuticals Announces Exclusive License Agreement With Saniona for SAN711